Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its plans to release a benchtop, R&D scale, Ultra Shear Technology(TM) (“UST”)-based BaroShear instrument to the market in the third quarter of 2020. Per … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Plans to Release Benchtop UST-Based BaroShear Instrument in Q3 2020”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer for six proprietary Ultra Shear Technology(TM) (“UST”)-based nanoemulsification systems for processing CBD oil into … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Receives Significant New Order, Expects Several More for Revolutionary Nanoemulsification System for Water-Soluble CBD Oil”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that its new and innovative Ultra Shear Technology(TM) (“UST”) platform was featured in Cannabis Brightline, one of North America’s leading cannabis publications. Per the … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Innovative UST Platform Featured in Leading North American Cannabis Publication”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the life sciences and other industries, was recently covered in a research report by Zacks Small Cap Research, a division of Zacks Investment Research. Among other highlights, Zacks maintained its $4.44 share price target … Continue reading “NetworkNewsBreaks – Zacks Small Cap Research Issues Update, Maintains Price Target on Pressure BioSciences Inc. (PBIO)”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the life sciences and other industries, today announced that in 2019 – for the second straight year – over 20 scientific papers highlighting the advantages of PBI’s patented pressure cycling technology (“PCT”) platform … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Second Straight Year of Strong Publication Numbers of Scientific Papers Citing Advantages of its PCT Platform”
Zacks has reiterated support for their initial $4.44 share price target for Pressure BioSciences PBIO’s fundamentals remain strong, with record sales of consumables and increased revenue from products and services over same quarter previous year Company anticipates doubling of total revenue in 2020, driven by anticipated sales of their proprietary BaroShear K45 System, which provides … Continue reading “Zacks Maintains Strong $4.44 Price Target for Pressure BioSciences Inc. (PBIO)”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, services, and platform solutions to the worldwide life sciences industry, today announced financial results for the third quarter ended September 30, 2019, provided a business update and offered limited guidance for FY2020. “We have consistently highlighted the importance … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Reports Q3 2019 Financial Results, Provides Business Update”
Pressure BioSciences (OTCQB: PBIO) (“PBI”) today announced that it will host a teleconference to discuss its third quarter 2019 financial results and to provide a business update. According to the update, Pressure BioSciences will include in the discussion progress made in its development of instrumentation for the nanoemulsification of oil and water. The call is … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference to Discuss Q3 2019 Financial Results, Provide Business Update”
Pressure BioSciences’ (OTCQB: PBIO) patented pressure cycling technology (“PCT”) platform was recently described as an integral part of women’s cancer research efforts during a presentation at the International Gynecologic Cancer Society conference in Brazil. An article discussing the company reads, “Pressure BioSciences’ PCT platform, as an integral part of the analytical trio, prepares the excised … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil”
Pressure BioSciences’ (OTCQB: PBIO) pressure cycling technology (“PCT”) platform was recently the subject of independent research carried out by Chinese and Australian scientists in which the platform demonstrated its proficiency in processing of preserved (“FFPE”) and fresh frozen biopsy tissue samples for the discovery of cancer biomarkers (http://nnw.fm/Rr8oT). An article discussing the company reads, “According to … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Proprietary PCT Platform Demonstrates Ability to Discover Cancer Biomarkers in Independent Research”
